ACTIVE

Audika

Financial year 2025 · closed on 31/12/2025
Net result
-46 k €
+95.4% YoY
Revenue
36,4 M €
+13.2% YoY
Equity
947,2 k €
-4.6% YoY
Workforce
163,2 ETP
+7.7% YoY

What does Audika do?

Audika is a Public limited company incorporated in 2017. Its main activity is: Retail sale of medical and orthopaedic goods in specialised stores. Its registered office is in Leuven. It employs on average 163,2 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0673.554.043
Incorporation
28/03/2017
Legal form
Public limited company
Registered office
Technologielaan 3
3001 Leuven · FlandreSee on map
Contributed capital
2 746 700,00 €
Latest accounts
31/12/2025
Average workforce
163,2 ETP
Joint committees (2)
  • 200
  • 20000
Signals
Good liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 7 financial years

2025202420232022202120182017
Income statement
Revenue36,4 M €32,1 M €22,3 M €13,2 M €
EBITDA5,3 M €4,6 M €2,6 M €568,7 k €533,8 k €276,2 k €32 k €
Operating result1,7 M €878,4 k €623,8 k €163,3 k €-88,2 k €-49,5 k €-137,9 k €
Net result-46 k €-1 M €-364,3 k €-69,6 k €-287,6 k €-67,8 k €-142,5 k €
Balance sheet
Equity947,2 k €993,2 k €2 M €2,4 M €2,4 M €1,8 M €1,9 M €
Total assets39,8 M €38,5 M €41,7 M €12,8 M €5,6 M €3 M €3,1 M €
Cash53,7 k €10 k €4,7 k €259 k €171,7 k €1,8 k €331,6 k €
Debts34,9 M €34,5 M €37,8 M €10,4 M €3 M €1,2 M €1,2 M €
Other
Workforce163,2 ETP151,6 ETP148,1 ETP88,0 ETP107,1 ETP11,3 ETP5,1 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 8 ended

Active mandates

Niels Wagner

Director · since 10 juin 2022 · until 18 mai 2028

Active
René Schneider

Director · since 10 juin 2022 · until 18 mai 2028

Active
Søren Nielsen

Chairman of the board of directors · since 10 juin 2022 · until 18 mai 2028

Active

Ended mandates

Soeren Nielsen

Chairman of the board of directors · since 10 juin 2022 · until 18 mai 2028

Ended
Søren Nielsen

Director · since 10 juin 2022 · until 18 mai 2028

Ended
Niels Wagner

Director · since 24 mars 2017 · until 01 avril 2022

Ended
Niels Wagner

Director · since 24 mars 2017 · until 10 juin 2022

Ended
At this address

Other companies at this address

CompanyCBE no.
BioRICSActive
0880.194.826
CAPVIDIAActive
0464.830.037
CUE - GRAPHICSActive
0454.279.902
DELCOMPActive
0454.418.274
Demant BelgiumActive
0795.669.323
0439.140.675
ES INVESTMENTActive
0471.645.474
FW4Active
0539.758.379
GOLDORActive
0474.928.232
iSensProActive
0729.580.352
0723.480.537
SkystromActive
0885.177.359
0825.300.942
Annual accounts

Full financial information

202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date03/07/202618/07/202530/08/202426/06/202306/07/202212/07/2021
General meeting19/06/202620/06/202506/06/202422/06/202310/06/202230/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

9 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202519/06/202603/07/2026DutchPDF
Full model31/12/202420/06/202518/07/2025DutchPDF
Full model31/12/202306/06/202430/08/2024DutchPDF
Full model31/12/202222/06/202326/06/2023DutchPDF
Abridged model31/12/202110/06/202206/07/2022DutchPDF
Abridged model31/12/202030/06/202112/07/2021DutchPDF
Abridged model31/12/201924/12/202022/02/2021DutchPDF
Abridged model31/12/201815/11/201913/01/2020DutchPDF
Abridged model31/12/201730/06/201820/07/2018DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 8 ended

Active mandates

Niels Wagner

Director · since 10 juin 2022 · until 18 mai 2028

Active
René Schneider

Director · since 10 juin 2022 · until 18 mai 2028

Active
Søren Nielsen

Chairman of the board of directors · since 10 juin 2022 · until 18 mai 2028

Active

Ended mandates

Soeren Nielsen

Chairman of the board of directors · since 10 juin 2022 · until 18 mai 2028

Ended
Søren Nielsen

Director · since 10 juin 2022 · until 18 mai 2028

Ended
Niels Wagner

Director · since 24 mars 2017 · until 01 avril 2022

Ended
Niels Wagner

Director · since 24 mars 2017 · until 10 juin 2022

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates25/02/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates21/02/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring29/09/2023
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring23/08/2023
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates28/07/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring18/07/2023
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring30/03/2023
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring27/12/2022
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-46 k €
  2. 2024
    Annual accounts 2024-1 M €
  3. 2023
    Annual accounts 2023-364,3 k €
  4. 2022
    Annual accounts 2022-69,6 k €
  5. 2021
    Annual accounts 2021-287,6 k €
  6. 2021
    Name changeAUDIKA
  7. 2018
    Annual accounts 2018-67,8 k €
  8. 2017
    Annual accounts 2017-142,5 k €
  9. 28/03/2017
    IncorporationPublic limited company
  10. 2017
    Name changeHearing Holding Belgium